Acute Stress Impairs Sensorimotor Gating Via the Neurosteroid Allopregnanolone in the Prefrontal Cortex
Overview
Authors
Affiliations
Ample evidence indicates that environmental stress impairs information processing, yet the underlying mechanisms remain partially elusive. We showed that, in several rodent models of psychopathology, the neurosteroid allopregnanolone (AP) reduces the prepulse inhibition (PPI) of the startle, a well-validated index of sensorimotor gating. Since this GABA receptor activator is synthesized in response to acute stress, we hypothesized its participation in stress-induced PPI deficits. Systemic AP administration reduced PPI in C57BL/6J mice and Long-Evans, but not Sprague-Dawley rats. These effects were reversed by isoallopregnanolone (isoAP), an endogenous AP antagonist, and the GABA receptor antagonist bicuculline and mimicked by AP infusions in the medial prefrontal cortex (mPFC). Building on these findings, we tested AP's implication in the PPI deficits produced by several complementary regimens of acute and short-term stress (footshock, restraint, predator exposure, and sleep deprivation). PPI was reduced by acute footshock, sleep deprivation as well as the combination of restraint and predator exposure in a time- and intensity-dependent fashion. Acute stress increased AP concentrations in the mPFC, and its detrimental effects on PPI were countered by systemic and intra-mPFC administration of isoAP. These results collectively indicate that acute stress impairs PPI by increasing AP content in the mPFC. The confirmation of these mechanisms across distinct animal models and several acute stressors strongly supports the translational value of these findings and warrants future research on the role of AP in information processing.
Prefrontal 5α-reductase 2 mediates male-specific acute stress response.
Cadeddu R, Braccagni G, Floris G, Branca C, Corridori E, Salviati S Sci Adv. 2025; 11(4):eadr0563.
PMID: 39841836 PMC: 11753402. DOI: 10.1126/sciadv.adr0563.
The role of neuroactive steroids in tic disorders.
Branca C, Bortolato M Neurosci Biobehav Rev. 2024; 160:105637.
PMID: 38519023 PMC: 11121756. DOI: 10.1016/j.neubiorev.2024.105637.
Cadeddu R, Van Zandt M, Santovito L, Odeh K, Anderson C, Flanagan D Neuropsychopharmacology. 2023; 48(9):1288-1299.
PMID: 37198434 PMC: 10354086. DOI: 10.1038/s41386-023-01603-6.
Frau R, Traccis F, Concas L, Cadeddu R, Mosher L, Nordkild P Psychopharmacology (Berl). 2023; 240(6):1359-1372.
PMID: 37129616 DOI: 10.1007/s00213-023-06375-x.